RxDoctor Payments Data

Shawna Harvey, OD

Optometrist · Waterloo, IANPI 1548757586

Payments from drug & device makers

$1,100in general payments, 2019–2025

Across 50 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$458
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$183
  • Johnson & Johnson Vision Care, Inc.$167
  • Shire North American Group Inc$77
  • Oyster Point Pharma, Inc.$47
  • AbbVie$34
  • plus $134 from 8 others

What the payments were for

  • Food & beverage$1,08198%
  • Gifts$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,100 in reported general payments places this provider in the 75th percentile of 559 optometrist providers in Iowa.

See all optometrist providers in Iowa

Medicare billing

Part B allowed, 2024
$110,830
Medicare patients
498
Services billed
1,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost57$32,502
RestasisCyclosporine31$20,927
XiidraLifitegrast22$18,845
Cyclosporine23$9,333
Latanoprost308$4,805
Brimonidine Tartrate26$3,692
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol11$3,165
TafluprostTafluprost/Pf12$2,197
Prednisolone Acetate24$1,422
Dexamethasone Sodium Phosphate21$821
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat80$809
Timolol Maleate60$765
Tobramycin-DexamethasoneTobramycin/Dexamethasone16$720
Dorzolamide Hcl17$314
Levobunolol Hcl14$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis$34$53,42988 claims
Bausch & Lomb Americas Inc.Xiidra$19$18,84522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 559 optometrist providers in Iowa.

Other optometrist in Waterloo

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →